In this respect, based on the identified correlations, we characterized the production of KYN, 3-HK, and KYNA in vitro using melanoma-derived BRAF wild type (wt) and BRAF V600E mutant cell lines cultured with primary CD4+ CD25− T-cells. Here, CD4 is linked to melanoma.